Insider Trading History of Hallal David

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Hallal David since 2015. This trader's CIK number is 1457477. At the time of last reporting, Hallal David was the Chief Executive Officer of Scholar Rock Holding Corp. (stock ticker symbol SRRK). Also see all insider trading activities at Scholar Rock Holding Corp.

Note that in the past Hallal David also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Iteos Therapeutics, Inc. (ITOS) by Hallal David

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 ITOS 0 $0 114,682 $1,164,403 114,682 $493,132
2022 ITOS 0 $0 29,615 $597,784 29,615 $113,125
2021 ITOS 0 $0 50,000 $2,178,500 50,000 $181,250

Yearly summary of insider trading at Alexion Pharmaceuticals, Inc. (ALXN) by Hallal David

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 ALXN 0 $0 15,057 $2,117,503 0 $0
2015 ALXN 0 $0 7,944 $1,400,331 0 $0

Yearly summary of insider trading at Scholar Rock Holding Corp (SRRK) by Hallal David

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2026 SRRK 0 $0 57,450 $2,453,115 0 $0

Yearly summary of insider trading at Kalaris Therapeutics, Inc. (ALVR) by Hallal David

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 ALVR 0 $0 1,157,004 $8,927,971 0 $0


Insider trading activities at 4 companies by Hallal David:

1. Iteos Therapeutics, Inc. (ITOS)

2. Alexion Pharmaceuticals, Inc. (ALXN)

3. Scholar Rock Holding Corp (SRRK)

4. Kalaris Therapeutics, Inc. (ALVR)

Table 1. Insider trading of Iteos Therapeutics, Inc. (ITOS) by Hallal David

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-06-04 ITOS Option Ex 38,227 4.30 164,376
2025-06-05 ITOS Option Ex 38,227 4.30 164,376
2025-06-04 ITOS Sale 38,227 10.07 384,945
2025-06-06 ITOS Option Ex 38,228 4.30 164,380
2025-06-05 ITOS Sale 38,227 10.15 388,004
2025-06-06 ITOS Sale 38,228 10.24 391,454
2022-06-08 ITOS Option Ex 28,444 3.80 108,172
2022-06-09 ITOS Option Ex 1,171 4.23 4,953
2022-06-08 ITOS Sale 28,444 20.21 574,938
2022-06-09 ITOS Sale 1,171 19.51 22,846
2021-12-20 ITOS Option Ex 50,000 3.62 181,250
2021-12-20 ITOS Sale 50,000 43.57 2,178,500

Table 2. Insider trading of Alexion Pharmaceuticals, Inc. (ALXN) by Hallal David

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-08-08 ALXN Sale 332 137.14 45,530
2016-04-01 ALXN Sale 1,414 136.04 192,360
2016-02-29 ALXN Sale 2,014 140.18 282,322
2016-02-05 ALXN Sale 6,722 142.86 960,291
2016-02-04 ALXN Sale 629 144.43 90,846
2016-02-08 ALXN Sale 3,946 138.41 546,154
2015-08-07 ALXN Sale 329 190.01 62,513
2015-08-04 ALXN Sale 612 196.52 120,270
2015-03-02 ALXN Sale 730 180.34 131,648
2015-02-10 ALXN Sale 1,980 171.15 338,877
2015-02-09 ALXN Sale 2,920 173.93 507,875
2015-02-03 ALXN Sale 765 174.02 133,125
2015-02-04 ALXN Sale 608 174.38 106,023

Table 3. Insider trading of Scholar Rock Holding Corp (SRRK) by Hallal David

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2026-01-13 SRRK Sale 57,450 42.70 2,453,115

Table 4. Insider trading of Kalaris Therapeutics, Inc. (ALVR) by Hallal David

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-10-19 ALVR Sale 600,000 8.45 5,070,000
2022-09-29 ALVR Sale 400,000 7.35 2,940,800
2022-07-21 ALVR Sale 4,227 5.33 22,529
2022-06-03 ALVR Sale 65,725 3.67 241,079
2022-04-21 ALVR Sale 4,227 5.87 24,812
2022-03-10 ALVR Sale 40,481 7.55 305,793
2022-03-11 ALVR Sale 25,244 7.37 186,073
2022-01-24 ALVR Sale 17,100 8.01 136,885

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hallal David (Chief Executive Officer of Scholar Rock Holding Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.